About RxInsider

Who We Are

RxInsider is a pharmaceutical industry intelligence publication covering deals, negotiations, policy, and the financial dynamics that shape drug markets. We serve pharmaceutical professionals, benefits consultants, healthcare investors, and policy practitioners who need to understand how pharmaceutical markets actually function.

Our Coverage

We cover eight distinct areas of the pharmaceutical industry: M&A and licensing deals, PBM and formulary negotiations, regulatory policy, late-stage pipeline analysis, earnings and pricing strategy, executive moves, original data analysis, and weekly intelligence roundups.

Editorial Independence

RxInsider does not accept sponsored content. Our coverage is independent of any pharmaceutical company, PBM, or industry association. All content is reviewed by human editors before publication. Sources are cited for all factual claims.

Publisher

RxInsider is published by BuiltForAI, LLC, part of a healthcare intelligence ecosystem serving patients, providers, and industry professionals across 35 specialized domains.